Plasticity of the HEK-293 cells, related to the culture media, as platform to produce a subunit vaccine against classical swine fever virus

[1]  P. Yuan,et al.  Optimization of Protein Expression in Mammalian Cells , 2018, Current protocols in protein science.

[2]  A. Petrov,et al.  Epidemiology, diagnosis and control of classical swine fever: Recent developments and future challenges , 2018, Transboundary and emerging diseases.

[3]  Y. Carpio,et al.  A single dose of the novel chimeric subunit vaccine E2-CD154 confers early full protection against classical swine fever virus. , 2017, Vaccine.

[4]  D. Covas,et al.  Approaches for recombinant human factor IX production in serum-free suspension cultures , 2016, Biotechnology Letters.

[5]  M. Galleni,et al.  Generation of a soluble recombinant trimeric form of bovine CD40L and its potential use as a vaccine adjuvant in cows. , 2015, Veterinary immunology and immunopathology.

[6]  M. Graninger,et al.  Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells , 2015, BMC Biotechnology.

[7]  Dae-Hee Lee,et al.  A novel psychrophilic alkaline phosphatase from the metagenome of tidal flat sediments , 2015, BMC Biotechnology.

[8]  C. Rivas,et al.  Effectiveness of the E2-Classical Swine Fever Virus Recombinant Vaccine Produced and Formulated within Whey from Genetically Transformed Goats , 2014, Clinical and Vaccine Immunology.

[9]  Bin Zhou,et al.  Generation and Efficacy Evaluation of Recombinant Classical Swine Fever Virus E2 Glycoprotein Expressed in Stable Transgenic Mammalian Cell Line , 2014, PloS one.

[10]  J. Cairó,et al.  HEK293 cell culture media study towards bioprocess optimization: Animal derived component free and animal derived component containing platforms. , 2014, Journal of bioscience and bioengineering.

[11]  Olivier Henry,et al.  Enhanced glycoprotein production in HEK-293 cells expressing pyruvate carboxylase. , 2011, Metabolic engineering.

[12]  L. Nielsen,et al.  Engineering a mammalian super producer , 2011 .

[13]  S. Gómez-Puerta,et al.  Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens. , 2011, Comparative immunology, microbiology and infectious diseases.

[14]  Michael Butler,et al.  Expression systems for therapeutic glycoprotein production. , 2009, Current opinion in biotechnology.

[15]  R. Dwek,et al.  N-glycosylation pattern of E2 glycoprotein from classical swine fever virus. , 2009, Journal of proteome research.

[16]  J. Kelly,et al.  Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells , 2008, BMC biotechnology.

[17]  L. Ganges,et al.  Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. , 2008, Vaccine.

[18]  U. Ziegler,et al.  [Vaccination of weaner pigs against classical swine fever with the subunit vaccine "Porcilis Pesti": influence of different immunization plans on excretion and transmission of challenge virus]. , 2002, Berliner und Munchener tierarztliche Wochenschrift.

[19]  G. M. De Mia,et al.  Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs. , 2001, Veterinary microbiology.

[20]  S. Gillies,et al.  A Dual-Function DNA Vaccine Encoding Carcinoembryonic Antigen and CD40 Ligand Trimer Induces T Cell-Mediated Protective Immunity Against Colon Cancer in Carcinoembryonic Antigen-Transgenic Mice1 , 2001, The Journal of Immunology.

[21]  R. Kroczek,et al.  The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. , 2001, Blood.

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[23]  V. Moennig,et al.  Introduction to classical swine fever: virus, disease and control policy. , 2000, Veterinary microbiology.

[24]  R. Moormann,et al.  Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. , 1999, Veterinary microbiology.

[25]  M. Hulst,et al.  Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera , 1993, Journal of virology.

[26]  A. Berns,et al.  Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera , 1991, Journal of virology.

[27]  G. Wensvoort,et al.  The protective value of vaccine-induced neutralising antibody titres in swine fever. , 1988, Veterinary microbiology.

[28]  A. Gielkens,et al.  The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. , 1984, Veterinary microbiology.

[29]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[30]  Elliot J. Lefkowitz,et al.  Virus taxonomy: classification and nomenclature of viruses , 2012 .

[31]  B. Szewczyk,et al.  Effect of N-glycosylation inhibition on the synthesis and processing of classical swine fever virus glycoproteins. , 2007, Acta biochimica Polonica.

[32]  S. Geisse,et al.  The Secrets of Transfection in Serumfree Suspension Culture , 2005 .

[33]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[34]  M. V. Regenmortel,et al.  Virus taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses. , 2000 .